Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × dehydroftorafur × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 10 Pancreatic Neoplasms 9 Rectal Neoplasms 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Colonic Neoplasms 4 Adenocarcinoma Of Esophagus 3 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Clinical Stage I Gastric Cancer AJCC v8 2 Appendiceal Neoplasms 2 Anus Neoplasms 2 Uterine Neoplasms 1 Tongue Neoplasms 1 Sinonasal undifferentiated carcinoma 1 Salivary Gland Neoplasms 1 Peritoneal Neoplasms 1 Paranasal Sinus Neoplasms 1 Pancreatic Intraductal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Metastatic Small Intestinal Adenocarcinoma 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Neoplasms 1 Keratosis, Actinic 1 Hypopharyngeal Neoplasms 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡